Overview

A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe to give L-743,872 to men with candidal esophagitis, an AIDS-related yeast infection in the esophagus.
Phase:
N/A
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Caspofungin